OFF-IABEI PRESCRIBING-JUSTIFYING UNAPPROVED MEDICINE

Main
OFF-IABEI PRESCRIBING-JUSTIFYING...

OFF-IABEI PRESCRIBING-JUSTIFYING UNAPPROVED MEDICINE

DAVID CAVAIIA

0 / 0

¿Qué tanto le ha gustado este libro?

¿De qué calidad es el archivo descargado?

Descargue el libro para evaluar su calidad

¿Cuál es la calidad de los archivos descargados?

Año:

2015

Editorial:

WILEY BIACK WEII

Idioma:

chinese

Páginas:

193

ISBN:

40876545

Archivo:

PDF, 68.40 MB

IPFS:

,

chinese, 2015

Leer en línea

Conversión a en curso

La conversión a ha fallado

También le puede interesar

Ronald Evens — Drug and Biological Development: From Molecule to Product and Beyond

Decision Resources Inc — The SAGE Handbook of Healthcare (Sage Handbooks)

Philippe Auby — Clinical Research in Paediatric Psychopharmacology: A Practical Overview of the Ethical, Scientific, and Regulatory Aspects

Ibis Sanchez-Serrano — The World's Health Care Crisis: From the Laboratory Bench to the Patient's Bedside

Tamas Bartfai and Graham V. Lees (Auth.) — The Future of Drug Discovery. Who Decides Which Diseases to Treat?

Divya Vohora; Gursharan Singh — Pharmaceutical Medicine and Translational Clinical Research

Odilia Osakwe, Syed A.A. Rizvi PhD PhD MSc MBA MS MRSC — Social Aspects of Drug Discovery, Development and Commercialization

Javed Ali, Sanjula Baboota — Regulatory Affairs in the Pharmaceutical Industry

Donald W. Light — The risks of prescription drugs

Cohen, I. Glenn; Lynch, Holly Fernandez — FDA in the twenty-first century : the challenges of regulating drugs and new technologies

Donald Light (editor) — The Risks of Prescription Drugs

Holly Fernandez Lynch (editor); I. Glenn Cohen (editor) — FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies

Bernice Z. Schacter — The New Medicines: How Drugs are Created, Approved, Marketed, and Sold

Jerry Avorn, M.D. — Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs

Committee on Accelerating Rare Diseases Research and Orphan Product Development, Institute of Medicine — Rare Diseases and Orphan Products: Accelerating Research and Development

Elias Mossialos, Monique Mrazek, Tom Walley — Regulating Pharmaceuticals in Europe (European Observatory on Health Systems and Policies)

Richard Blum, Andrew Herxheimer, Catherine Stenzl, Jasper Woodcock (editors) — Pharmaceuticals and Health Policy: International Perspectives on Provision and Control of Medicines

Clinical Professor Ronald P. Evens Pharm D., FCCP (auth.), Clinical Professor Ronald P. Evens Pharm D., FCCP (eds.) — Drug and Biological Development: From Molecule to Product and Beyond

Lionel D. Edwards, Andrew J. Fletcher, Anthony W. Fox, Peter D. Stonier — Principles and Practice of Pharmaceutical Medicine

Andrew J. Fletcher, Lionel D. Edwards, Anthony W. Fox, Peter D. Stonier — Practice and Principles of Pharmaceutical Medicine

John Griffin, John O'Grady — Regulation of Medical Products

Paul Ruschmann — Prescription and Non-prescription Drugs (Point Counterpoint)

Arthur A. Daemmrich — Pharmacopolitics: Drug Regulation in the United States and Germany

Fred C. Pampel — Prescription Drugs

Cavalla, David — Off-label prescribing : justifying unapproved medicine

Iqbal Ramzan — Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians and Other Health Practitioners

Iqbal Ramzan — Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians, and Other Health Practitioners

Jeffrey S. Barrett — Fundamentals of Drug Development

Christine Bond — Using Medicines Information

Hugh L’etang (eds.) — Regulation and Restraint in Contemporary Medicine in the UK and USA

Dr Denis Burley, Christobel Haward, Brenda Mullinger (eds.) — The Focus for Pharmaceutical Knowledge: The Proceedings of the Sixth International Meeting of Pharmaceutical Physicians Brighton, England, June 1987

Lionel D. Edwards, Anthony W. Fox, Peter D. Stonier — Principles and Practice of Pharmaceutical Medicine, Third Edition

Friedhoff, Lawrence Tim — New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients

Emily Jackson — Law and the Regulation of Medicines

Henry H. Sun, Jingyan Meng, Kaijing Yan, — The Book of Chinese Medicine, Volume 2

Términos más frecuentes